Tower Research Capital LLC (Trc) Sutro Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,677 shares of STRO stock, worth $6,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,677

Previous 11,881 69.05%

Holding current value

$6,912

Previous $34,000 64.71%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.88 - $5.01 $23,627 - $41,102	-8,204 Reduced 69.05%	3,677 $12,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.33 $21,190 - $38,679	7,257 Added 156.94%	11,881 $34,000
Q1 2024 May 15, 2024	SELL	$3.27 - $5.65 $15,604 - $26,961	-4,772 Reduced 50.79%	4,624 $26,000
Q4 2023 Feb 13, 2024	SELL	$2.07 - $4.54 $11,865 - $26,023	-5,732 Reduced 37.89%	9,396 $40,000
Q3 2023 Nov 14, 2023	BUY	$3.29 - $4.9 $38,519 - $57,369	11,708 Added 342.34%	15,128 $52,000
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $1,083 - $1,499	255 Added 8.06%	3,420 $15,000
Q1 2023 May 09, 2023	BUY	$4.48 - $8.45 $8,162 - $15,395	1,822 Added 135.67%	3,165 $15,000
Q4 2022 Feb 10, 2023	SELL	$5.41 - $8.08 $10,316 - $15,408	-1,907 Reduced 58.68%	1,343 $11,000
Q3 2022 Nov 10, 2022	SELL	$5.17 - $7.11 $12,687 - $17,447	-2,454 Reduced 43.02%	3,250 $18,000
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $15,246 - $40,015	4,471 Added 362.61%	5,704 $30,000
Q1 2022 May 12, 2022	SELL	$7.78 - $15.31 $32,753 - $64,455	-4,210 Reduced 77.35%	1,233 $10,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $34,599 - $57,130	2,428 Added 80.53%	5,443 $81,000
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $7,089 - $9,399	-420 Reduced 12.23%	3,015 $57,000
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $2,271 - $3,001	-126 Reduced 3.54%	3,435 $64,000
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $29,907 - $40,593	1,474 Added 70.63%	3,561 $81,000
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $165,892 - $391,545	-16,328 Reduced 88.67%	2,087 $45,000
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $85,805 - $151,658	11,533 Added 167.58%	18,415 $185,000
Q2 2020 Aug 13, 2020	BUY	$7.24 - $11.05 $49,825 - $76,046	6,882 New	6,882 $53,000
Q4 2019 Feb 07, 2020	SELL	$8.15 - $11.39 $896 - $1,252	-110 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$7.91 - $11.76 $8,637 - $12,841	-1,092 Reduced 90.85%	110 $1,000
Q2 2019 Aug 13, 2019	BUY	$9.69 - $12.23 $9,379 - $11,838	968 Added 413.68%	1,202 $14,000
Q1 2019 May 14, 2019	SELL	$8.8 - $11.87 $46,499 - $62,721	-5,284 Reduced 95.76%	234 $3,000
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $47,951 - $81,942	5,518 New	5,518 $49,000

Others Institutions Holding STRO

# of Institutions

137

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $98.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Sutro Biopharma, Inc. Transaction History